Return to previous page

HMM304 - Therapeutic Development

Unit details

Year2016 unit information
Enrolment modes:Trimester 2: Burwood (Melbourne), Waurn Ponds (Geelong)
Credit point(s):1
EFTSL value:0.125
Unit chair:

Sarah Shigdar





Incompatible with:


Contact hours:

3 x 1 hour classes per week, and Cloud (online) exercises, case studies, debates and discussions


This unit describes how therapeutic targets are identified and how new therapies are developed for human use. It will provide an overview of the major therapeutic classes, including synthetic compounds, natural products, vaccines, nutriceuticals and other biological agents, and covers the therapeutic development pipeline, encompassing target identification and validation, therapeutic discovery and development, pre-clinical trials and toxicity testing.


Assessment task 1: Mid-trimester test (45 minutes) 20%
Assessment task 2: Written report (1500 words) 30%
Assessment task 3: Examination (2 hours) 50%

Prescribed texts

Raymond G. Hill & Humphrey P. Rang. Drug Discovery and development second edition 2013.

Unit Fee Information

All Commonwealth Supported Place (CSP), fee paying undergraduate and pre-2016 commencing students

Unit fee information available soon

2016 commencing International and full fee paying postgraduate domestic students

Your units are priced based on the course you are enrolled in. Please refer to the current year's course entry to estimate the unit cost.

You can calculate the cost of each unit by using the following calculation:

Course fee x unit EFTSL value = unit price

Return to previous page